International Journal of Hematology

Article	Citations
Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation	69
Acquired hypofibrinogenemia in a patient with multiple myeloma	65
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment	39
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma	39
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia	31
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells	30
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature	23
Carcinocythemia diagnosed on peripheral blood clot sections	23
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study	22
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan	21
Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation	21
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy	19
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice	19
Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population	19
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells	18
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib	18
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era	17
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets	17
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma	17
Post-transfusion purpura and adult primary thrombocytopenia	17
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors	17
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma	15
Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan	15
Isolated thrombosis after COVID-19 vaccination: case series	14
Current and emerging therapeutic strategies in adult T-cell leukemia–lymphoma	14

Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases	14
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia	13
SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia	13
Primary pancreatic diffuse large B-cell lymphoma, appearing as an asymptomatic bulky mass with the duct-penetrating sign	13
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy	13
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma	13
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma—overview	13
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study	13
HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA	12
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)	12
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors	12
Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia	11
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A	11
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia	11
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus	11
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)	11
Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM	10
Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic	10
Evolution and optimization of therapies for acute lymphoblastic leukemia in infants	10
Expression of activated integrin β7 in multiple myeloma patients	10
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a	10
Ten years’ experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities	10
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen	10
Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma	10
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome	10
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays	10
DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report	9
Multiple myeloma with high-risk cytogenetics and its treatment approach	9
Guest Editorial: what can be done to improve cancer immunotherapies?	9
Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia	9
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study	9
Optimization of lymphapheresis for manufacturing autologous CAR-T cells	9
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome	9
Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma	9
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023	9
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia	9
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study	9
Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic	9
Nodal mature plasmacytoid dendritic cell proliferation mimicking lymphoma in a patient with CALR-mutated myelofibrosis	8
A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation	8
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial	8
Correction to: A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	8
Effect of delivery mode on postnatal platelet count dynamics in neonates born to mothers with immune thrombocytopenia	8
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds	8
Comparative inhibitory effects of bepotastine and diphenhydramine on rituximab-induced infusion reactions	8
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients	8
Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution	8
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation	8
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies	8
Assay variables and early clinical evaluation of low-angle light scattering for platelet function analysis	8

Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation	8
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era	8
Combined tumor necrosis factor-α (−308 G/A) and tumor necrosis factor-β (+ 252 A/G) nucleotide polymorphisms and chronicity in Egyptian children with immune thrombocytopenia	8
Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation	8
Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice	7
Clinical features of immature leukemias in children	7
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study	7
Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)	7
Resilient T-cell responses in patients with advanced cancers	7
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia	7
Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants	7
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	7
An adult case of refractory autoimmune neutropenia after liver transplantation	7
Risk prediction for delayed clearance of high-dose methotrexate in pediatric hematological malignancies by machine learning	7
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia	7
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit	7
Auer rods in mature granulocytes in peripheral blood	7
Detection of Talaromyces marneffei in a HIV-infected patient from peripheral blood observation through Sysmex XN WNF/WNR channels	7
Correction to: Patient’s age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome	7
Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach	7
COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm	6
Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia	6
Dysregulated hemostasis in acute promyelocytic leukemia	6
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series	6
Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation	6
Leukemic-phase mucosa-associated lymphoid tissue lymphoma	6
A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial	6
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia	6
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia	6
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag	6
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid	6
Correction to: Somatic SETBP1 mutations in myeloid neoplasms	6
Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol	6
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system	6
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myeloma	6
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases	6
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis	6
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia	6
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors	6
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center	5
VEXAS syndrome	5
JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	5
A case of posttransplant isolated extramedullary relapse of acute lymphoblastic leukemia achieving durable treatment-free remission with blinatumomab and donor lymphocyte infusion	5
Neuropeptide TIP39 induces autophagy in PTH2 receptor-positive myeloid neoplasms	5
Recent advances in understanding the biology of follicular lymphoma	5
Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation	5
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review	5
Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)	5
Prognostic value of lymphoid marker CD7 expression in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in first morphological complete remission	5
Fulminant type I cryoglobulinemic glomerulonephritis with unique ultrastructural plugs: a case report	5
Novel immunotherapies in multiple myeloma	5
Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children	5
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes	5
Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia	5
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM	5
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency	5
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval	5
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marke	5
Correction: JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	5
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells	5
Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation	5
Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes	5
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia	5
Sarcoma-like appearance but pathologic Hodgkin lymphoma	5
Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients	5
Favorable prognosis of vaccine-associated immune thrombocytopenia in children is correlated with young age at vaccination: Retrospective survey of a nationwide disease registry	5
Heme as a differentiation-regulatory transcriptional cofactor	5
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis	5
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB	5
The mutual crosstalk between iron and erythropoiesis	5
Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?	5
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura	5
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation	5
Pseudo-Chediak–Higashi inclusions and Auer rods in a case of therapy-related acute monocytic leukemia	5
FLT3 targeting in the modern era: from clonal selection to combination therapies	5
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 4. Mantle cell lymphoma (MCL)	5
FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloanti	5
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio	5
Stem cell regulation and dynamics in myeloid malignancies	4
Septic shock caused by Capnocytophaga canimorsus in a patient with heterozygous Pelger-Huët anomaly	4

A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	4
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease	4
Prevention of acute graft-versus-host disease in adult T-cell leukemia–lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation	4
Bringing mass spectrometry into the care of patients with multiple myeloma	4
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein–Barr virus infection	4
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review	4
Mature T-cell and NK-cell lymphomas: updates on molecular genetic features	4
In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry	4
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review	4
Anakinra for the treatment of adult secondary HLH: a retrospective experience	4
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma	4
Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency	4
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination	4
Retrospective comparison of reinfusion procedures and subsequent leukopenia in autologous stem cell transplantation	4
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease	4
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes	4
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine	4
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line	4
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria	4
Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation	4
Recent advances in AML with mutated NPM1	4
Factor XII deficiency: a clinical and molecular genetic study	4
HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia	4
Bosutinib-induced lung injury: a report of two cases and literature review	4
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis	4
Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report	4
Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study	4
Reply to the Dr. Murphy’s comment	4
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development	4
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples	4
Blasts engulfing erythrocytes: an unusual morphological finding in adult early T-precursor acute lymphoblastic leukemia	4
Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic	4
Multifocal osteonecrosis after stem cell transplantation	4
An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma	4
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan	4
Guest editorial: recent progress in pediatric leukemia	4
Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis o	4
Correction: JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)	3
Iliopsoas haemorrhage complicated by femoral neuropathy in patients with haemophilia: a case series report	3
Histological confirmation and radiotherapy facilitate continuation of epcoritamab in a patient with tumor flare reaction	3
Prevalence and molecular spectrum of α- and β-globin gene mutations in Hainan, China	3
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia	3
T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia	3
Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma	3
Chronic graft-versus-host disease myelitis successfully treated with rituximab	3
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study	3
Quality of life of children and adolescents with hemophilia receiving low-dose prophylactic treatment	3
Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations	3
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives	3
Very early death within 30 days after diagnosis in patients with acute myeloid leukemia	3
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)	3
Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation	3
Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes	3
Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal	3
Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan	3
Platelet and large platelet ratios are useful in predicting severity of COVID-19	3
Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH	3
Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation	3
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy	3
JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma—2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associa	3
Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders	3
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation	3
Histiocytic sarcoma following CAR T-cell therapy: a case report	3
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency	3
Strong association between insufficient plasma exchange and fatal outcomes in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura	3
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1	3
Iron deficiency and phlebotomy in patients with polycythemia vera	3
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma	3
Bispecific antibodies for multiple myeloma: past, present and future	3
Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma	3
Prediction of major bleeding events in 1381 patients with essential thrombocythemia	3
Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood	3
Recent progress in the management of pediatric chronic myeloid leukemia	3
Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells	3
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy	3
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation	3
Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group	3
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation	3
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 p	3
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia	3
Epigenetic regulation by ASXL1 in myeloid malignancies	3
Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva	3
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: significance of guidelines developed for each underlying disease	3
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?	3
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine	3
Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth	3
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study	3
Relationship between serum zinc level and sepsis-induced coagulopathy	3
Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging	3
Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission	3
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm	3
Peculiar pleural effusion and hemophagocytic lymphohistiocytosis associated with myelodysplastic syndromes	3
Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review	3
Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after fir	3
Ultrasonographic scoring system for SOS/VOD in pediatric hematopoietic stem cell transplant recipients	3